EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis

Steven D Nathan, Peter Smith, Chunqin Deng, Maria De Salvo, Wim Wuyts, Juana Pavie-Gallegos, Jin Woo Song, Mordechai R Kramer, Christopher S King, John A Mackintosh, Daniel Chambers, Georgina Viviana Miranda und 7 weitere

New England Journal of Medicine · 09.07.2026 · 395 (2) · 127-137

DOI: 10.1056/nejmoa2512911 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 09.07.2026. Verfasst von Steven D Nathan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Inova Fairfax Hospital, Falls Church, VA. Hauptthemen laut MEDLINE: Antifibrotic Agents, Cough, Epoprostenol, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrotic AgentsCoughEpoprostenolIdiopathic Pulmonary FibrosisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, InhalationAntihypertensive AgentsDisease ProgressionDouble-Blind MethodQuality of LifeTreatment OutcomeVital Capacity

Substanzen

Antifibrotic AgentsAntihypertensive AgentsEpoprostenoltreprostinil

Autor:innen und Institutionen

  • Inova Fairfax Hospital, Falls Church, VA.
  • United Therapeutics, Durham, NC.
  • Centro Médico Dra. De Salvo, Buenos Aires.
  • Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Centro Respiratorio Integral Cenresin, Quillota, Chile.
  • Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

ORCID-Profile: Vincent Cottin

Zitieren

APA

Nathan, S. D., Smith, P., Deng, C., De Salvo, M., Wuyts, W., Pavie-Gallegos, J., Song, J. W., Kramer, M. R., King, C. S., Mackintosh, J. A., Chambers, D., Miranda, G. V., Breytenbach, N., Peterson, L., Bell, H., Flaherty, K. R., Behr, J., Cottin, V., & TETON-2 Trial Investigators (2026). Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis. New England Journal of Medicine, 395(2), 127-137. https://doi.org/10.1056/nejmoa2512911

Vancouver

Nathan SD, Smith P, Deng C, De Salvo M, Wuyts W, Pavie-Gallegos J, et al. Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 2026;395(2):127-137. doi:10.1056/nejmoa2512911

BibTeX
@article{Nathan2026,
  author = {Nathan, Steven D and Smith, Peter and Deng, Chunqin and De Salvo, Maria and Wuyts, Wim and Pavie-Gallegos, Juana and Song, Jin Woo and Kramer, Mordechai R and King, Christopher S and Mackintosh, John A and Chambers, Daniel and Miranda, Georgina Viviana and Breytenbach, Natalie and Peterson, Leigh and Bell, Heidi and Flaherty, Kevin R and Behr, Juergen and Cottin, Vincent and TETON-2 Trial Investigators, TETON-2 Trial Investigators},
  title = {Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {2},
  pages = {127--137},
  doi = {10.1056/nejmoa2512911}
}
Kostenlos starten →